Cargando…
Health‐care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis
BACKGROUND: Due to limited treatment options, many patients with diabetic gastroparesis (DG) or idiopathic gastroparesis (IG) experience inadequate symptom control resulting in increased health‐care resource utilization (HRU) and associated costs. We compared all‐cause HRU and health‐care costs over...
Autores principales: | Chen, Yaozhu J., Tang, Wenxi, Ionescu‐Ittu, Raluca, Ayyagari, Rajeev, Wu, Eric, Huh, Susanna Y., Parkman, Henry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539633/ https://www.ncbi.nlm.nih.gov/pubmed/35352855 http://dx.doi.org/10.1111/nmo.14366 |
Ejemplares similares
-
Ultrastructural differences between diabetic and idiopathic gastroparesis
por: Faussone-Pellegrini, Maria Simonetta, et al.
Publicado: (2012) -
Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017) -
The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
por: Revicki, Dennis A., et al.
Publicado: (2018) -
Gastroparesis
por: Miles, Matthew, et al.
Publicado: (2023) -
Gastroparésie
por: Miles, Matthew, et al.
Publicado: (2023)